Burns, T. F., Fujiwara, Y., Lin, V. T. G., Negrao, M. V., Mateos, L. A. L., Yamaguchi, M., Levin, P. A., Singh, P. P., Zhou, Y., Merced, A., Fasnacht, N., Willard, M. D., Grul, C. M. V., Murciano-Goroff, Y. R. (2026). 1L olomorasib plus pembrolizumab +/- chemotherapy in
                    <i>KRAS</i>
                    G12C-mutant NSCLC patients +/- a prior cycle of SOC: Results from LOXO-RAS 20001 and SUNRAY-01.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8570